Bulletin 2010/29 - European Patent Office
Bulletin 2010/29 - European Patent Office
Bulletin 2010/29 - European Patent Office
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
(A61K) II.1(1)<br />
22.03.2003 GB 0306640<br />
22.03.2003 GB 0306644<br />
22.03.2003 GB 0306650<br />
22.03.2003 GB 0306651<br />
22.03.2003 GB 0306654<br />
04.04.2003 PCT/GB03/01525<br />
24.05.2003 GB 0312062<br />
01.08.2003 PCT/GB03/03285<br />
03.10.2003 GB 0323130<br />
07.01.2004 PCT/GB2004/000046<br />
23.01.2004 PCT/GB2004/000263<br />
(54) • BEHANDLUNG VON ALLERGISCHEN<br />
ERKRANKUNGEN UNTER VERWENDUNG<br />
EINES MODULATORS DES NOTCH SIG-<br />
NALING PATHWAY<br />
• TREATMENT OF ALLERGIC DISEASES<br />
USING A MODULATOR OF THE NOTCH<br />
SIGNALING PATHWAY<br />
• TRAITEMENT DE MALADIES ALLERGI-<br />
QUES UTILISANT UN MODULATEUR DE<br />
LA VOIE DE SIGNALISATION NOTCH<br />
(73) Celldex Therapeutics Limited, 23 Cambridge<br />
Science Park, Suite 54 Cambridge CB4 0EY,<br />
GB<br />
(72) BODMER, Mark William, Lorantis Limited,<br />
Cambridge CB4 0PE, GB<br />
BRIEND, Emmanuel Cyrille Pascal, Lorantis<br />
Limited, Cambridge CB4 OPE, GB<br />
CHAMPION, Brian Robert, Lorantis Limited,<br />
Cambridge CB4 0PE, GB<br />
LENNARD, Andrew Christopher, Lorantis<br />
Limited, Cambridge CB4 0PE, GB<br />
MCKENZIE, Grahame James, Lorantis Limited,<br />
Cambridge CB4 0PE, GB<br />
RAGNO, Silvia, Lorantis Limited, Cambridge<br />
CB4 0PE, GB<br />
TUGAL, Tamara, Lorantis Limited, Cambridge<br />
CB4 0PE, GB<br />
WARD, George Albert, Lorantis Limited,<br />
Cambridge CB4 OPE, GB<br />
YOUNG, Lesley Lynn, Lorantis Limited,<br />
Cambridge CB4 0PE, GB<br />
(74) Mallalieu, Catherine Louise, et al, D Young &<br />
Co LLP 120 Holborn, London EC1N 2DY, GB<br />
A61K 39/00 → (51) C07K 14/705<br />
A61K 39/00 → (51) C12Q 1/37<br />
(51) A61K 39/095 (11) 1 741 442 B1<br />
A61K 39/385 A61P 31/04<br />
C12P 19/04 C12R 1/36<br />
(25) En (26) En<br />
(21) 06075175.7 (22) 20.06.2002<br />
(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />
LU MC NL PT SE TR<br />
(43) 10.01.2007<br />
(30) 20.06.2001 GB 0115176<br />
(54) • Neisseria meningitidis Kombinationimpfstoffe<br />
• Neisseria meningitidis combination vaccines<br />
• Vaccins combinés contre Neisseria meningitidis<br />
(73) Novartis AG, Lichtstrasse 35, 4056 Basel, CH<br />
(72) Costantino, Paolo, 53100 Siena, IT<br />
(74) Marshall, Cameron John, et al, Carpmaels &<br />
Ransford 43-45 Bloomsbury Square, London<br />
WC1A 2RA, GB<br />
(60) 09075005.0 / 2 184 071<br />
09075006.8 / 2 189 165<br />
09075009.2<br />
09075010.0<br />
09075011.8<br />
(62) 02755452.6 / 1 401 489<br />
(51) A61K 39/10 (11) 1 667 712 B1<br />
(25) En (26) En<br />
(21) 04765806.7 (22) 01.10.2004<br />
Europäisches <strong>Patent</strong>blatt<br />
<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />
<strong>Bulletin</strong> européen des brevets<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IT LI LU MC NL PL PT RO SE SI SK<br />
TR<br />
HR LT LV<br />
(43) 14.06.2006<br />
(86) EP 2004/011082 01.10.2004<br />
(87) WO 2005/032584 2005/15 14.04.2005<br />
(30) 02.10.2003 GB 0323113<br />
02.10.2003 GB 0323112<br />
(54) • B. PERTUSSIS ANTIGENE UND IHRE<br />
VERWENDUNG BEI DER VAKZINIERUNG<br />
• B. PERTUSSIS ANTIGENS AND USE<br />
THEREOF IN VACCINATION<br />
• ANTIGENES DE B. PERTUSSIS ET LEUR<br />
UTILISATION DANS LA VACCINATION<br />
(73) GlaxoSmithKline Biologicals s.a., rue de<br />
l'Institut 89, 1330 Rixensart, BE<br />
(72) CASTADO, Cindy, GlaxoSmithKline Biologicals<br />
s.a., B-1330 Rixensart, BE<br />
DENOEL, Philippe, GlaxoSmithKline Biologicals<br />
s.a., B-1330 Rixensart, BE<br />
GODFROID, Fabrice, GlaxoSmithKline Biologicals<br />
s.a., B-1330 Rixensart, BE<br />
POOLMAN, Jan, GlaxoSmithKline Biologicals<br />
s.a., B-1330 Rixensart, BE<br />
(74) Lubienski, Michael John, et al, GlaxoSmithKline<br />
Corporate Intellectual Property<br />
CN925.1 980 Great West Road, Brentford,<br />
Middlesex TW8 9GS, GB<br />
(51) A61K 39/12 (11) 1 790 332 B1<br />
A61K 9/19 A61K 36/06<br />
(25) Ja (26) En<br />
(21) 05782348.6 (22) 09.09.2005<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />
SE SI SK TR<br />
(43) 30.05.2007<br />
(86) JP 2005/016638 09.09.2005<br />
(87) WO 2006/028214 2006/11 16.03.2006<br />
(30) 10.09.2004 JP 2004263580<br />
(54) • IMPFSTOFF GEGEN HUMANES PAPILLO-<br />
MAVIRUS ZUR ORALEN VERABREICHUNG<br />
• HUMAN PAPILLOMA VIRUS VACCINE FOR<br />
ORAL ADMINISTRATION<br />
• VACCIN POUR ADMINISTRATION ORALE<br />
CONTRE LE PAPPILOMAVIRUS HUMAIN<br />
(73) Asahi Glass Company, Limited, 12-1, Yurakucho<br />
1-chome, Chiyoda-ku, Tokyo 100-<br />
8405, JP<br />
National University Corporation Kanazawa<br />
University, Nu 7, Kakuma-machi, Kanazawashi,<br />
Ishikawa 920-1164, JP<br />
(72) SASAGAWA, Toshiyuki, kanazawa University,<br />
Ishikawa 9201164, JP<br />
TOHDA, Hideki, Asahi Glass Company,<br />
Limited, Kanagawa 2218755, JP<br />
HAMA, Yuko, Asahi Glass Company, Limited,<br />
Kanagawa 2218755, JP<br />
(74) Müller-Boré & Partner <strong>Patent</strong>anwälte, Grafinger<br />
Strasse 2, 81671 München, DE<br />
A61K 39/36 → (51) C07K 14/415<br />
A61K 39/385 → (51) A61K 39/095<br />
(51) A61K 39/395 (11) 0 702 566 B1<br />
(25) En (26) En<br />
(21) 94916785.2 (22) 16.05.1994<br />
(84) AT BE CH DE DK ES FR GB GR IE IT LI LU<br />
MC NL PT SE<br />
(43) 27.03.1996<br />
(86) US 1994/005433 16.05.1994<br />
(87) WO 1994/026307 1994/26 24.11.1994<br />
(30) 17.05.1993 US 63399<br />
444<br />
<strong>Patent</strong>e<br />
<strong>Patent</strong>s<br />
Brevets (<strong>29</strong>/<strong>2010</strong>) 21.07.<strong>2010</strong><br />
(54) • INHIBITION DES MIGRATIONS-INHIBI-<br />
TIONS-FAKTORS IN DER BEHANDLUNG<br />
VON KRANKHEITEN BEI DENEN EINE<br />
CYTOKIN-VERMITTELTE TOXIZITÄT EINE<br />
ROLLE SPIELT<br />
• INHIBITION OF MIGRATION INHIBITORY<br />
FACTOR IN THE TREATMENT OF DIS-<br />
EASES INVOLVING CYTOKINE-MEDIATED<br />
TOXICITY<br />
• INHIBITION DE LA MIGRATION DU FAC-<br />
TEUR INHIBITEUR DANS LE TRAITEMENT<br />
DE MALADIES IMPLIQUANT UNE TOXI-<br />
CITE TRANSMISE PAR LA CYTOKINE<br />
(73) Cytokine Pharmasciences, Inc, 150 South<br />
Warner Road, Suite 150, King of Prussia, PA<br />
19406, US<br />
(72) BUCALA, Richard J., New York, NY 10021,<br />
US<br />
MITCHELL, Robert A., New York, NY 10009,<br />
US<br />
BERNHAGEN, Jurgen, New York, NY 10028,<br />
US<br />
CALANDRA, Thierry F., New York, NY 10021,<br />
US<br />
CERAMI, Anthony, Shelter Island, NY 11964,<br />
US<br />
(74) Bentz, Jean-Paul, et al, Cabinet Weinstein<br />
56A Rue du Faubourg Saint-Honoré, 75008<br />
Paris, FR<br />
(60) 06017611.2 / 1 741 779<br />
(51) A61K 39/395 (11) 1 682 177 B1<br />
(25) En (26) En<br />
(21) 04810417.8 (22) 04.11.2004<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LU MC NL PL PT RO SE SI<br />
SK TR<br />
(43) 26.07.2006<br />
(86) US 2004/036954 04.11.2004<br />
(87) WO 2005/044304 2005/20 19.05.2005<br />
(30) 04.11.2003 US 517337 P<br />
26.11.2003 US 525579 P<br />
27.04.2004 US 565710 P<br />
21.09.2004 US 611794 P<br />
(54) • VERWENDUNG VON ANTAGONISTEN-<br />
ANTI-CD40-ANTIKÖRPERN ZUR BEHAND-<br />
LUNG VON CHRONISCH LYMPHOZYTI-<br />
SCHER LEUKÄMIE<br />
• USE OF ANTAGONIST ANTI-CD40 ANTI-<br />
BODIES FOR TREATMENT OF CHRONIC<br />
LYMPHOCYTIC LEUKEMIA<br />
• UTILISATION D'ANTICORPS ANTI-CD40<br />
ANTAGONISTES POUR LE TRAITEMENT<br />
DE LA LEUCEMIE LYMPHOCYTIQUE<br />
CHRONIQUE<br />
(73) Novartis Vaccines and Diagnostics, Inc.,<br />
4560 Horton Street, Emeryville, CA 94608,<br />
US<br />
(72) LONG, Li, Emeryville, CA 94662-8097, US<br />
LUQMAN, Mohammad, Emeryville, CA<br />
94662-8097, US<br />
YABANNAVAR, Asha, Emeryville, CA 94662-<br />
8097, US<br />
ZAROR, Isabel, Emeryville, CA 94662-8097,<br />
US<br />
AUKERMAN, Sharon, Lea, Emeryville, CA<br />
94662-8097, US<br />
(74) Marshall, Cameron John, et al, Carpmaels &<br />
Ransford 43-45 Bloomsbury Square, London<br />
WC1A 2RA, GB<br />
(51) A61K 39/395 (11) 1 684 805 B1<br />
(25) En (26) En<br />
(21) 04818358.6 (22) 04.11.2004<br />
(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />
GR HU IE IS IT LI LU MC NL PL PT RO SE SI<br />
SK TR<br />
(43) 02.08.2006<br />
(86) US 2004/037281 04.11.2004<br />
(87) WO 2005/044855 2005/20 19.05.2005
Change language